Global Veterinary Biologics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Veterinary Biologics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Veterinary Biologics Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Vaccines
1.2.3 Monoclonal Antibodies
1.3 Market Segment by Application
1.3.1 Global Veterinary Biologics Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Llivestock
1.3.3 Equine
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Veterinary Biologics Market Size (2017-2028)
2.1.1 Global Veterinary Biologics Revenue (2017-2028)
2.1.2 Global Veterinary Biologics Sales (2017-2028)
2.2 Global Veterinary Biologics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Veterinary Biologics Sales by Regions (2017-2022)
2.2.2 Global Veterinary Biologics Revenue by Regions (2017-2022)
2.3 Global Veterinary Biologics Market Size Forecast by Region
2.3.1 Global Veterinary Biologics Sales Forecast by Region (2023-2028)
2.3.2 Global Veterinary Biologics Revenue Forecast by Region (2023-2028)
2.4 Global Top Veterinary Biologics Regions (Countries) Ranking by Market Size
2.5 Veterinary Biologics Market Dynamics
2.5.1 Veterinary Biologics Market Trends
2.5.2 Veterinary Biologics Market Drivers
2.5.3 Veterinary Biologics Market Challenges
2.5.4 Veterinary Biologics Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Veterinary Biologics Manufacturers by Sales (2017-2022)
3.1.1 Global Veterinary Biologics Sales by Manufacturers (2017-2022)
3.1.2 Global Veterinary Biologics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Veterinary Biologics Sales in 2021
3.2 Global Top Manufacturers Veterinary Biologics by Revenue
3.2.1 Global Veterinary Biologics Revenue by Manufacturers (2017-2022)
3.2.2 Top Veterinary Biologics Manufacturers Covered: Ranking by Revenue
3.2.3 Global Veterinary Biologics Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Veterinary Biologics Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Biologics as of 2021)
3.4 Global Veterinary Biologics Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Veterinary Biologics Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Veterinary Biologics Market
3.7 Key Manufacturers Veterinary Biologics Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Veterinary Biologics Market Size by Type
4.1 Global Veterinary Biologics Historic Market Review by Type (2017-2022)
4.1.1 Global Veterinary Biologics Sales Market Share by Type (2017-2022)
4.1.2 Global Veterinary Biologics Revenue Market Share by Type (2017-2022)
4.1.3 Veterinary Biologics Price by Type (2017-2022)
4.2 Global Veterinary Biologics Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Veterinary Biologics Sales Forecast by Type (2023-2028)
4.2.2 Global Veterinary Biologics Revenue Forecast by Type (2023-2028)
4.2.3 Veterinary Biologics Price Forecast by Type (2023-2028)
5 Global Veterinary Biologics Market Size by Application
5.1 Global Veterinary Biologics Historic Market Review by Application (2017-2022)
5.1.1 Global Veterinary Biologics Sales Market Share by Application (2017-2022)
5.1.2 Global Veterinary Biologics Revenue Market Share by Application (2017-2022)
5.1.3 Veterinary Biologics Price by Application (2017-2022)
5.2 Global Veterinary Biologics Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Veterinary Biologics Sales Forecast by Application (2023-2028)
5.2.2 Global Veterinary Biologics Revenue Forecast by Application (2023-2028)
5.2.3 Veterinary Biologics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Veterinary Biologics Sales Breakdown by Company
6.1.1 North America Veterinary Biologics Sales by Company (2017-2022)
6.1.2 North America Veterinary Biologics Revenue by Company (2017-2022)
6.2 North America Veterinary Biologics Market Size by Type
6.2.1 North America Veterinary Biologics Sales by Type (2017-2028)
6.2.2 North America Veterinary Biologics Revenue by Type (2017-2028)
6.3 North America Veterinary Biologics Market Size by Application
6.3.1 North America Veterinary Biologics Sales by Application (2017-2028)
6.3.2 North America Veterinary Biologics Revenue by Application (2017-2028)
6.4 North America Veterinary Biologics Market Size by Country
6.4.1 North America Veterinary Biologics Sales by Country (2017-2028)
6.4.2 North America Veterinary Biologics Revenue by Country (2017-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Veterinary Biologics Sales Breakdown by Company
7.1.1 Europe Veterinary Biologics Sales by Company (2017-2022)
7.1.2 Europe Veterinary Biologics Revenue by Company (2017-2022)
7.2 Europe Veterinary Biologics Market Size by Type
7.2.1 Europe Veterinary Biologics Sales by Type (2017-2028)
7.2.2 Europe Veterinary Biologics Revenue by Type (2017-2028)
7.3 Europe Veterinary Biologics Market Size by Application
7.3.1 Europe Veterinary Biologics Sales by Application (2017-2028)
7.3.2 Europe Veterinary Biologics Revenue by Application (2017-2028)
7.4 Europe Veterinary Biologics Market Size by Country
7.4.1 Europe Veterinary Biologics Sales by Country (2017-2028)
7.4.2 Europe Veterinary Biologics Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Veterinary Biologics Sales Breakdown by Company
8.1.1 Asia Pacific Veterinary Biologics Sales by Company (2017-2022)
8.1.2 Asia Pacific Veterinary Biologics Revenue by Company (2017-2022)
8.2 Asia Pacific Veterinary Biologics Market Size by Type
8.2.1 Asia Pacific Veterinary Biologics Sales by Type (2017-2028)
8.2.2 Asia Pacific Veterinary Biologics Revenue by Type (2017-2028)
8.3 Asia Pacific Veterinary Biologics Market Size by Application
8.3.1 Asia Pacific Veterinary Biologics Sales by Application (2017-2028)
8.3.2 Asia Pacific Veterinary Biologics Revenue by Application (2017-2028)
8.4 Asia Pacific Veterinary Biologics Market Size by Region
8.4.1 Asia Pacific Veterinary Biologics Sales by Region
8.4.2 Asia Pacific Veterinary Biologics Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Veterinary Biologics Sales Breakdown by Company
9.1.1 Latin America Veterinary Biologics Sales by Company (2017-2022)
9.1.2 Latin America Veterinary Biologics Revenue by Company (2017-2022)
9.2 Latin America Veterinary Biologics Market Size by Type
9.2.1 Latin America Veterinary Biologics Sales by Type (2017-2028)
9.2.2 Latin America Veterinary Biologics Revenue by Type (2017-2028)
9.3 Latin America Veterinary Biologics Market Size by Application
9.3.1 Latin America Veterinary Biologics Sales by Application (2017-2028)
9.3.2 Latin America Veterinary Biologics Revenue by Application (2017-2028)
9.4 Latin America Veterinary Biologics Market Size by Country
9.4.1 Latin America Veterinary Biologics Sales by Country (2017-2028)
9.4.2 Latin America Veterinary Biologics Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Veterinary Biologics Sales Breakdown by Company
10.1.1 Middle East and Africa Veterinary Biologics Sales by Company (2017-2022)
10.1.2 Middle East and Africa Veterinary Biologics Revenue by Company (2017-2022)
10.2 Middle East and Africa Veterinary Biologics Market Size by Type
10.2.1 Middle East and Africa Veterinary Biologics Sales by Type (2017-2028)
10.2.2 Middle East and Africa Veterinary Biologics Revenue by Type (2017-2028)
10.3 Middle East and Africa Veterinary Biologics Market Size by Application
10.3.1 Middle East and Africa Veterinary Biologics Sales by Application (2017-2028)
10.3.2 Middle East and Africa Veterinary Biologics Revenue by Application (2017-2028)
10.4 Middle East and Africa Veterinary Biologics Market Size by Country
10.4.1 Middle East and Africa Veterinary Biologics Sales by Country (2017-2028)
10.4.2 Middle East and Africa Veterinary Biologics Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Merck Veterinary Biologics Products and Services
11.1.5 Merck Veterinary Biologics SWOT Analysis
11.1.6 Merck Recent Developments
11.2 Zoetis
11.2.1 Zoetis Corporation Information
11.2.2 Zoetis Overview
11.2.3 Zoetis Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Zoetis Veterinary Biologics Products and Services
11.2.5 Zoetis Veterinary Biologics SWOT Analysis
11.2.6 Zoetis Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Veterinary Biologics Products and Services
11.3.5 Boehringer Ingelheim Veterinary Biologics SWOT Analysis
11.3.6 Boehringer Ingelheim Recent Developments
11.4 Ceva
11.4.1 Ceva Corporation Information
11.4.2 Ceva Overview
11.4.3 Ceva Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Ceva Veterinary Biologics Products and Services
11.4.5 Ceva Veterinary Biologics SWOT Analysis
11.4.6 Ceva Recent Developments
11.5 CAHIC
11.5.1 CAHIC Corporation Information
11.5.2 CAHIC Overview
11.5.3 CAHIC Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 CAHIC Veterinary Biologics Products and Services
11.5.5 CAHIC Veterinary Biologics SWOT Analysis
11.5.6 CAHIC Recent Developments
11.6 HVRI
11.6.1 HVRI Corporation Information
11.6.2 HVRI Overview
11.6.3 HVRI Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 HVRI Veterinary Biologics Products and Services
11.6.5 HVRI Veterinary Biologics SWOT Analysis
11.6.6 HVRI Recent Developments
11.7 Ringpu Biology
11.7.1 Ringpu Biology Corporation Information
11.7.2 Ringpu Biology Overview
11.7.3 Ringpu Biology Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Ringpu Biology Veterinary Biologics Products and Services
11.7.5 Ringpu Biology Veterinary Biologics SWOT Analysis
11.7.6 Ringpu Biology Recent Developments
11.8 Yebio
11.8.1 Yebio Corporation Information
11.8.2 Yebio Overview
11.8.3 Yebio Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Yebio Veterinary Biologics Products and Services
11.8.5 Yebio Veterinary Biologics SWOT Analysis
11.8.6 Yebio Recent Developments
11.9 DHN
11.9.1 DHN Corporation Information
11.9.2 DHN Overview
11.9.3 DHN Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 DHN Veterinary Biologics Products and Services
11.9.5 DHN Veterinary Biologics SWOT Analysis
11.9.6 DHN Recent Developments
11.10 WINSUN
11.10.1 WINSUN Corporation Information
11.10.2 WINSUN Overview
11.10.3 WINSUN Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 WINSUN Veterinary Biologics Products and Services
11.10.5 WINSUN Veterinary Biologics SWOT Analysis
11.10.6 WINSUN Recent Developments
11.11 Elanco/Eli Lilly
11.11.1 Elanco/Eli Lilly Corporation Information
11.11.2 Elanco/Eli Lilly Overview
11.11.3 Elanco/Eli Lilly Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Elanco/Eli Lilly Veterinary Biologics Products and Services
11.11.5 Elanco/Eli Lilly Recent Developments
11.12 Virbac
11.12.1 Virbac Corporation Information
11.12.2 Virbac Overview
11.12.3 Virbac Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 Virbac Veterinary Biologics Products and Services
11.12.5 Virbac Recent Developments
11.13 Jinyu Bio-Technology
11.13.1 Jinyu Bio-Technology Corporation Information
11.13.2 Jinyu Bio-Technology Overview
11.13.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.13.4 Jinyu Bio-Technology Veterinary Biologics Products and Services
11.13.5 Jinyu Bio-Technology Recent Developments
11.14 ChengDu Tecbond
11.14.1 ChengDu Tecbond Corporation Information
11.14.2 ChengDu Tecbond Overview
11.14.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.14.4 ChengDu Tecbond Veterinary Biologics Products and Services
11.14.5 ChengDu Tecbond Recent Developments
11.15 CAVAC
11.15.1 CAVAC Corporation Information
11.15.2 CAVAC Overview
11.15.3 CAVAC Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.15.4 CAVAC Veterinary Biologics Products and Services
11.15.5 CAVAC Recent Developments
11.16 Kyoto Biken
11.16.1 Kyoto Biken Corporation Information
11.16.2 Kyoto Biken Overview
11.16.3 Kyoto Biken Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.16.4 Kyoto Biken Veterinary Biologics Products and Services
11.16.5 Kyoto Biken Recent Developments
11.17 FATRO
11.17.1 FATRO Corporation Information
11.17.2 FATRO Overview
11.17.3 FATRO Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.17.4 FATRO Veterinary Biologics Products and Services
11.17.5 FATRO Recent Developments
11.18 Vaksindo
11.18.1 Vaksindo Corporation Information
11.18.2 Vaksindo Overview
11.18.3 Vaksindo Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.18.4 Vaksindo Veterinary Biologics Products and Services
11.18.5 Vaksindo Recent Developments
11.19 Bio-Labs
11.19.1 Bio-Labs Corporation Information
11.19.2 Bio-Labs Overview
11.19.3 Bio-Labs Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.19.4 Bio-Labs Veterinary Biologics Products and Services
11.19.5 Bio-Labs Recent Developments
11.20 Avimex Animal
11.20.1 Avimex Animal Corporation Information
11.20.2 Avimex Animal Overview
11.20.3 Avimex Animal Veterinary Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.20.4 Avimex Animal Veterinary Biologics Products and Services
11.20.5 Avimex Animal Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Veterinary Biologics Value Chain Analysis
12.2 Veterinary Biologics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Veterinary Biologics Production Mode & Process
12.4 Veterinary Biologics Sales and Marketing
12.4.1 Veterinary Biologics Sales Channels
12.4.2 Veterinary Biologics Distributors
12.5 Veterinary Biologics Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Veterinary Biologics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Vaccines
Table 3. Major Manufacturers of Monoclonal Antibodies
Table 4. Global Veterinary Biologics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Veterinary Biologics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Veterinary Biologics Sales by Region (2017-2022) & (K Units)
Table 7. Global Veterinary Biologics Sales Market Share by Region (2017-2022)
Table 8. Global Veterinary Biologics Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Veterinary Biologics Revenue Market Share by Region (2017-2022)
Table 10. Global Veterinary Biologics Sales Forecast by Region (2023-2028) & (K Units)
Table 11. Global Veterinary Biologics Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Veterinary Biologics Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Veterinary Biologics Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Veterinary Biologics Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Veterinary Biologics Market Trends
Table 16. Veterinary Biologics Market Drivers
Table 17. Veterinary Biologics Market Challenges
Table 18. Veterinary Biologics Market Restraints
Table 19. Global Veterinary Biologics Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Veterinary Biologics Sales Share by Manufacturers (2017-2022)
Table 21. Global Veterinary Biologics Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Veterinary Biologics Manufacturers by Revenue (US$ Million) in 2021
Table 23. Veterinary Biologics Revenue Share by Manufacturers (2017-2022)
Table 24. Global Veterinary Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Biologics as of 2021)
Table 26. Key Manufacturers Veterinary Biologics Average Selling Price (ASP) & (2017-2022) & (US$/Unit)
Table 27. Key Manufacturers Veterinary Biologics Plants/Factories Distribution
Table 28. Key Manufacturers Veterinary Biologics Area Served
Table 29. Date of Key Manufacturers Enter into Veterinary Biologics Market
Table 30. Key Manufacturers Veterinary Biologics Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Veterinary Biologics Sales (K Units) by Type (2017-2022)
Table 33. Global Veterinary Biologics Sales Share by Type (2017-2022)
Table 34. Global Veterinary Biologics Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Veterinary Biologics Price (K Units) by Type (2017-2022)
Table 36. Global Veterinary Biologics Sales (K Units) by Type (2023-2028)
Table 37. Global Veterinary Biologics Sales Share by Type (2023-2028)
Table 38. Global Veterinary Biologics Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Veterinary Biologics Revenue Share by Type (2023-2028)
Table 40. Global Veterinary Biologics Price (K Units) by Type (2023-2028)
Table 41. Global Veterinary Biologics Sales (K Units) by Application (2017-2022)
Table 42. Global Veterinary Biologics Sales Share by Application (2017-2022)
Table 43. Global Veterinary Biologics Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Veterinary Biologics Price (K Units) by Application (2017-2022)
Table 45. Global Veterinary Biologics Sales (K Units) by Application (2023-2028)
Table 46. Global Veterinary Biologics Sales Share by Application (2023-2028)
Table 47. Global Veterinary Biologics Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Veterinary Biologics Revenue Share by Application (2023-2028)
Table 49. Global Veterinary Biologics Price (K Units) by Application (2023-2028)
Table 50. North America Veterinary Biologics Sales by Company (2017-2022) & (K Units)
Table 51. North America Veterinary Biologics Sales Market Share by Company (2017-2022)
Table 52. North America Veterinary Biologics Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Veterinary Biologics Revenue Market Share by Company (2017-2022)
Table 54. North America Veterinary Biologics Sales by Type (2017-2022) & (K Units)
Table 55. North America Veterinary Biologics Sales by Type (2023-2028) & (K Units)
Table 56. North America Veterinary Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Veterinary Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Veterinary Biologics Sales by Application (2017-2022) & (K Units)
Table 59. North America Veterinary Biologics Sales by Application (2023-2028) & (K Units)
Table 60. North America Veterinary Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Veterinary Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Veterinary Biologics Sales by Country (2017-2022) & (K Units)
Table 63. North America Veterinary Biologics Sales by Country (2023-2028) & (K Units)
Table 64. North America Veterinary Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Veterinary Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Veterinary Biologics Sales by Company (2017-2022) & (K Units)
Table 67. Europe Veterinary Biologics Sales Market Share by Company (2017-2022)
Table 68. Europe Veterinary Biologics Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Veterinary Biologics Revenue Market Share by Company (2017-2022)
Table 70. Europe Veterinary Biologics Sales by Type (2017-2022) & (K Units)
Table 71. Europe Veterinary Biologics Sales by Type (2023-2028) & (K Units)
Table 72. Europe Veterinary Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Veterinary Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Veterinary Biologics Sales by Application (2017-2022) & (K Units)
Table 75. Europe Veterinary Biologics Sales by Application (2023-2028) & (K Units)
Table 76. Europe Veterinary Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Veterinary Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Veterinary Biologics Sales by Country (2017-2022) & (K Units)
Table 79. Europe Veterinary Biologics Sales by Country (2023-2028) & (K Units)
Table 80. Europe Veterinary Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Veterinary Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Veterinary Biologics Sales by Company (2017-2022) & (K Units)
Table 83. Asia Pacific Veterinary Biologics Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Veterinary Biologics Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Veterinary Biologics Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Veterinary Biologics Sales by Type (2017-2022) & (K Units)
Table 87. Asia Pacific Veterinary Biologics Sales by Type (2023-2028) & (K Units)
Table 88. Asia Pacific Veterinary Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Veterinary Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Veterinary Biologics Sales by Application (2017-2022) & (K Units)
Table 91. Asia Pacific Veterinary Biologics Sales by Application (2023-2028) & (K Units)
Table 92. Asia Pacific Veterinary Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Veterinary Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Veterinary Biologics Sales by Region (2017-2022) & (K Units)
Table 95. Asia Pacific Veterinary Biologics Sales by Region (2023-2028) & (K Units)
Table 96. Asia Pacific Veterinary Biologics Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Veterinary Biologics Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Veterinary Biologics Sales by Company (2017-2022) & (K Units)
Table 99. Latin America Veterinary Biologics Sales Market Share by Company (2017-2022)
Table 100. Latin America Veterinary Biologics Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Veterinary Biologics Revenue Market Share by Company (2017-2022)
Table 102. Latin America Veterinary Biologics Sales by Type (2017-2022) & (K Units)
Table 103. Latin America Veterinary Biologics Sales by Type (2023-2028) & (K Units)
Table 104. Latin America Veterinary Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Veterinary Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Veterinary Biologics Sales by Application (2017-2022) & (K Units)
Table 107. Latin America Veterinary Biologics Sales by Application (2023-2028) & (K Units)
Table 108. Latin America Veterinary Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Veterinary Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Veterinary Biologics Sales by Country (2017-2022) & (K Units)
Table 111. Latin America Veterinary Biologics Sales by Country (2023-2028) & (K Units)
Table 112. Latin America Veterinary Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Veterinary Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Veterinary Biologics Sales by Company (2017-2022) & (K Units)
Table 115. Middle East and Africa Veterinary Biologics Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Veterinary Biologics Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Veterinary Biologics Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Veterinary Biologics Sales by Type (2017-2022) & (K Units)
Table 119. Middle East and Africa Veterinary Biologics Sales by Type (2023-2028) & (K Units)
Table 120. Middle East and Africa Veterinary Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Veterinary Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Veterinary Biologics Sales by Application (2017-2022) & (K Units)
Table 123. Middle East and Africa Veterinary Biologics Sales by Application (2023-2028) & (K Units)
Table 124. Middle East and Africa Veterinary Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Veterinary Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Veterinary Biologics Sales by Country (2017-2022) & (K Units)
Table 127. Middle East and Africa Veterinary Biologics Sales by Country (2023-2028) & (K Units)
Table 128. Middle East and Africa Veterinary Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Veterinary Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 130. Merck Corporation Information
Table 131. Merck Description and Overview
Table 132. Merck Veterinary Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 133. Merck Veterinary Biologics Product and Services
Table 134. Merck Veterinary Biologics SWOT Analysis
Table 135. Merck Recent Developments
Table 136. Zoetis Corporation Information
Table 137. Zoetis Description and Overview
Table 138. Zoetis Veterinary Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 139. Zoetis Veterinary Biologics Product and Services
Table 140. Zoetis Veterinary Biologics SWOT Analysis
Table 141. Zoetis Recent Developments
Table 142. Boehringer Ingelheim Corporation Information
Table 143. Boehringer Ingelheim Description and Overview
Table 144. Boehringer Ingelheim Veterinary Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 145. Boehringer Ingelheim Veterinary Biologics Product and Services
Table 146. Boehringer Ingelheim Veterinary Biologics SWOT Analysis
Table 147. Boehringer Ingelheim Recent Developments
Table 148. Ceva Corporation Information
Table 149. Ceva Description and Overview
Table 150. Ceva Veterinary Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 151. Ceva Veterinary Biologics Product and Services
Table 152. Ceva Veterinary Biologics SWOT Analysis
Table 153. Ceva Recent Developments
Table 154. CAHIC Corporation Information
Table 155. CAHIC Description and Overview
Table 156. CAHIC Veterinary Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 157. CAHIC Veterinary Biologics Product and Services
Table 158. CAHIC Veterinary Biologics SWOT Analysis
Table 159. CAHIC Recent Developments
Table 160. HVRI Corporation Information
Table 161. HVRI Description and Overview
Table 162. HVRI Veterinary Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 163. HVRI Veterinary Biologics Product and Services
Table 164. HVRI Veterinary Biologics SWOT Analysis
Table 165. HVRI Recent Developments
Table 166. Ringpu Biology Corporation Information
Table 167. Ringpu Biology Description and Overview
Table 168. Ringpu Biology Veterinary Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 169. Ringpu Biology Veterinary Biologics Product and Services
Table 170. Ringpu Biology Veterinary Biologics SWOT Analysis
Table 171. Ringpu Biology Recent Developments
Table 172. Yebio Corporation Information
Table 173. Yebio Description and Overview
Table 174. Yebio Veterinary Biologics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 175. Yebio Veterinary Biologics Product and Services
Table 176. Yebio Veterinary Biologics SWOT Analysis
Table 177. Yebio Recent Developments
Table 178. DHN Corporation Information
Table 179.

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Classical Swine Fever Vaccines Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......

Global Tylosin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......

Global Animal Parasiticides Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......

Global Newcastle Disease Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......

Global Classical Swine Fever Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126

According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......

Global Veterinary Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151

According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......

Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......

Global Veterinary Products for Companion Animals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......

Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115

According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs